Home > Clinical Trials

Saved trials

Completed
NCT01838850
Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Combination Therapy in Patients With Hypertension Not Controlled With Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy
344 Enrollment(s)
39 Study location(s)
Interventional (Phase III)
Essential Hypertension
Terminated
NCT01132768
The Confirmatory Olmesartan Plaque Regression Study
114 Enrollment(s)
0 Study location(s)
Interventional (Phase IV)
Essential Hypertension
Carotid Plaque
Completed
NCT01101009
Comparison of Sevikar® and the Combination of Perindopril/Amlodipine on Central Blood Pressure
486 Enrollment(s)
15 Study location(s)
Interventional (Phase IV)
Hypertension
Completed
NCT00891267
Effect of Two Doses of Olmesartan Medoxomil and Amlodipine on Vascular Markers in Hypertensive Patients With Metabolic Syndrome
60 Enrollment(s)
0 Study location(s)
Interventional (Phase III)
Metabolic Syndrome
Hypertension
Terminated
NCT00679484
Study to Demonstrate the Non-inferiority of Olmesartan Medoxomil Versus Candesartan Cilexetil in Reducing Blood B-type (or Brain) Natriuretic Peptide Levels at Week 24
400 Enrollment(s)
0 Study location(s)
Interventional (Phase III)
Chronic Heart Failure
High Blood B-type (or Brain) Natriuretic Peptide (BNP) Level
Completed
NCT00676845
Study to Determine if Olmesartan Medoxomil Has the Potential to Benefit the Cardiovascular System in Terms of Arterial Protection
133 Enrollment(s)
0 Study location(s)
Interventional (Phase III)
Metabolic Syndrome
Hypertension
Completed
NCT00220233
Olmesartan as an add-on to Amlodipine in Hypertension
632 Enrollment(s)
0 Study location(s)
Interventional (Phase III)
Essential Hypertension
Completed
NCT00220220
Amlodipine as add-on to Olmesartan in Hypertension
429 Enrollment(s)
0 Study location(s)
Interventional (Phase III)
Essential Hypertension